AGM Statement

RNS Number : 8116P
Anpario PLC
22 June 2022
 

-------------------------------------------------------------------

 

INTERIM RESULTS DATE CORRECTION

 

The following amendment(s) has (have) been made to the ' AGM Statement' announcement released on 16/06/2022 at 07:00 under RNS No 0160P.

 

The last line of the RNS, "The Company's interims for the six months period ended 30 June 2021 are expected to be announced on 14 September 2021.", contained incorrect dates. The year for both dates should have been 2022.

 

The last line should have read as follows. "The Company's interims for the six months period ended 30 June 2022 are expected to be announced on 14 September 2022."

 

All other details remain unchanged.

 

The full amended text is shown below.

 

-------------------------------------------------------------------

 

 

Anpario plc

("Anpario" or the "Company")

 

AGM Statement

 

Anpario plc, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity , is holding its AGM later today. Kate Allum, Chairman, will make the following statement:

 

"Group sales for the five months to 31 May 2022 are just ahead of last year which we consider a good performance given China's recent Covid lockdown and the Russia - Ukraine conflict, both of which have affected our sales performance.  As anticipated, we experienced significant raw material price inflation, which has remained at elevated levels, and combined with historically high logistics costs has led to a fall in our gross margins.  We have though, as a priority, been successfully passing on this inflation through planned sales price increases and overheads are being closely managed.

 

To mitigate the continued disruption in global supply chains we have increased finished goods inventory in our subsidiaries worldwide and increased raw material stockholding at our production site following the recent expansion and upgrade in storage capacity.  It is vital that we maintain continuity of supply to our customers who are experiencing significant cost pressures from the high price of animal feed.  Encouragingly, international travel and tourism is increasing and should lead to a corresponding uplift in meat consumption. 

 

We are excited by the potential of both existing and new products including pHorce® which is proving its value to pig producers worried about virus-contaminated feed and as a replacement for zinc oxide (ZnO) which is banned in piglet diets from June 2022 in the European Union.  Our new omega 3 supplement, Optomega® Algae, has generated a lot of interest due to its sustainable source, from which we expect to convert this interest into growing sales.  The Company continues to invest in both product technology and its global sales channels to deliver effective innovative solutions for the animal production industry.

 

We expect the challenging environment to continue until the end of the year, but Anpario's broad range of products, geographic diversity and strong financial position makes for a robust business and gives us confidence in our ability to navigate the current uncertainties and continue with the profitable development of the Company."

 

The Company's interims for the six months period ended 30 June 2022 are expected to be announced on 14 September 2022.

 

 

 

Enquiries:

 

Anpario plc

Richard Edwards, CEO

+44(0) 777 6417 129

Marc Wilson, Group Finance Director

+44(0) 1909 537380

 

Peel Hunt LLP (Nomad and broker)

+44 (0)20 7418 8900

Adrian Trimmings

Andrew Clark

Lalit Bose

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFLFFIRLIFFIF

Companies

Anpario (ANP)
UK 100

Latest directors dealings